Whipplewood Advisors’s Bio-Techne TECH Stock Holding History

Whipplewood Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$209	–	988
2026 Q1	$209	Buy	+4	New	+$240	﹤0.01%	1033
2025 Q3	–	Sell	-4	Closed	-$206	–	1061
2025 Q2	$206	Sell	4 -1,210	-100%	-$60.8K	﹤0.01%	1175
2025 Q1	$235	Buy	1,214 +1,210	+30,250%	+$82K	﹤0.01%	1183
2024 Q4	$288	Buy	+4	New	+$294	﹤0.01%	1151

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Whipplewood Advisors's TECH Position: Q2 2026 in Review

Whipplewood Advisors sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 4 shares — an estimated $209 sold.

Whipplewood Advisors first reported a position in TECH in Q4 2024 and held it in 4 quarters. The position peaked at $288 in Q4 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Whipplewood Advisors reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Whipplewood Advisors sold 4 Bio-Techne shares in Q2 2026, an estimated $209.
Whipplewood Advisors first reported a position in Bio-Techne in Q4 2024 and held it in 4 quarters.
Whipplewood Advisors's Bio-Techne position peaked at $288 in Q4 2024.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.